Emergency room prescriptions for acetaminophen (Tylenol) among pregnant women significantly decreased following a White House briefing where former President Trump falsely claimed the painkiller could cause autism, according to a new peer-reviewed study published in The Lancet. The analysis of nearly 90,000 ER visits revealed a 10% drop in prescriptions after the September briefing, although rates later partially recovered.
The Study Findings
Researchers found no similar decline in acetaminophen prescriptions for non-pregnant women visiting the same emergency rooms during the same 11-week period. This suggests the decrease in prescriptions was directly related to the public statements about Tylenol and autism. The study underscores how quickly misinformation can affect healthcare decisions, even in critical situations.
Why This Matters
The rapid shift in prescribing behavior is concerning because untreated fevers during pregnancy can lead to neurological problems in infants. Medical organizations like the American College of Obstetricians and Gynecologists maintain that acetaminophen remains the safest fever-reducing option for pregnant women when used as directed.
The White House Briefing
During the briefing, President Trump urged pregnant women to avoid acetaminophen, stating: “Don’t take Tylenol. Don’t take it. Fight like hell not to take it.” The claims were based on unsupported theories, and no credible scientific evidence links acetaminophen to autism.
The Consequences
The incident highlights the dangers of spreading health misinformation from high-profile platforms, potentially jeopardizing the health of both mothers and children. The study’s findings underscore the need for clear, evidence-based health communication and a critical evaluation of claims made by public figures.
This study is a stark reminder that misinformation can have immediate and measurable consequences in healthcare, and that trust in medical guidance must be upheld to ensure the safety of vulnerable populations.
